12.07.2015 Views

Immunological mechanisms in human reproduction - itslearning

Immunological mechanisms in human reproduction - itslearning

Immunological mechanisms in human reproduction - itslearning

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Immunological</strong><strong>mechanisms</strong> <strong>in</strong> <strong>human</strong><strong>reproduction</strong>MOL8002Molecular <strong>mechanisms</strong> of host defenceNovember 2009Guro Dalheim OlsenHuman <strong>reproduction</strong> research group, IKM, NTNUhttp://www.ntnu.no/dmf/ikm/cellebiologi/reproduksjon


Agenda• Pregnancy• Trophoblasts• The placenta• Inflammation – pre-eclampsiaeclampsia, metabolicsyndrome and cardiovascular diseases• Toll-likelike receptors• The HUNT study• Suggested read<strong>in</strong>g


Postulations of pregnancy• Pregnancy is a condition of immunologic armistice.• The maternal-fetal<strong>in</strong>teraction is a major challenge forthe immune system, and a state of immune tolerancehas to be established between the coexist<strong>in</strong>g motherand fetus.• Some postulations of pregnancy:1. Natural immune suppression: : a general immune suppressionstate is generated dur<strong>in</strong>g pregnancy to favour immuneacceptance between the mother and fetus.2. Fetal cells (the(trophoblasts) have to <strong>in</strong>teract with maternalimmune cells: expression of HLA.3. Placenta is an immune privileged site: <strong>mechanisms</strong> fordestroy<strong>in</strong>g activated immune cells.


Trophoblasts• Embryonic stem cells with outstand<strong>in</strong>g capasity of adapt<strong>in</strong>g tochang<strong>in</strong>g environments, tissue remodell<strong>in</strong>g and organdevelopment.• Cells form<strong>in</strong>g the outer layer of a blastocystcyst. Provide nutrients tothe embryo and develop <strong>in</strong>to a large part of the placenta.• Formed dur<strong>in</strong>g the first stage of pregnancy and are the first cellsto differentiate from the fertilized egg.• Cytotrophoblasts: : forms the <strong>in</strong>ner layers• Syncytiotrophoblasts: : forms the outer layers• Villous syncytiotrophoblasts: grow <strong>in</strong> a few areas and createanchor<strong>in</strong>g coloumns <strong>in</strong>to maternal tissues• Extravillous trophoblasts: <strong>in</strong>vade the decidua


Moffet-K<strong>in</strong>g A, Nature Rev Immunol 2002; 2 (9): 656.• CT: Cytotrophoblast• T: Trophoblast• F: Fibr<strong>in</strong>oid material• E: Endovascular trophoblast• GC: Placental-bed giant cells• K: NK cells• M: Macrophages• L: T cells


The placenta• Constitutes a physical and immunological barrier,protect<strong>in</strong>g the fetus aga<strong>in</strong>st <strong>in</strong>vad<strong>in</strong>g <strong>in</strong>fectious agentsand <strong>in</strong>flammation.• A pregnancy-specific component of the <strong>in</strong>nateimmune system.• Supplies the fetus with oxygen and nutrients, andallows fetal waste to be disposed via the maternalkidneys.• Develops from the same sperm and egg cells that formthe fetus, and functions as a fetomaternal organ withtwo components, the fetal part (Chorion(frondosum),and the maternal part (Decidua(basalis).


Photo: Ir<strong>in</strong>a P. Eide


Photo: Ir<strong>in</strong>a P. Eide


Inflammationhttp://www.chronicprostatitis.com/images/f3.jpg


The <strong>in</strong>flammatory response andpregnancy• Normal pregnancy is characterized by a mild systemic<strong>in</strong>flammatory response. . The mild <strong>in</strong>flammatory changes do not<strong>in</strong>dicate illness.• Resembles the acute phase response: activated endothelium,<strong>in</strong>creased plasma fibr<strong>in</strong>ogen, PAI-1,caeruloplasm<strong>in</strong>, redusedplasma album<strong>in</strong>, <strong>in</strong>crease of CRP.• Dur<strong>in</strong>g first trimester: leukocytosis, activated neutrophils and<strong>in</strong>creased phagocytosis.• Strengthened systemic <strong>in</strong>flammatory response as pregnancyadvances, peak<strong>in</strong>g dur<strong>in</strong>g the third trimester (<strong>in</strong>crease(of IL-6,TNF-a, circulat<strong>in</strong>g markers of oxidative stress, some times<strong>in</strong>sul<strong>in</strong> resistance).• A more vigorous systemic <strong>in</strong>flammatory response than normalpregnancy: pre-eclampsiaeclampsia.


The amount of microparticles<strong>in</strong>creases dur<strong>in</strong>g pregnancy1. trim 2. trim 3. trimDur<strong>in</strong>g normal pregnancy:Small amounts ofmicroparticles that are takencare of by the maternalimmune system.Syncytiotrophoblast microparticles (SMBM)b<strong>in</strong>d to maternal monocytes, myeloiddendrittic cells, and stimulate PBL toproduce pro<strong>in</strong>flammatory cytok<strong>in</strong>es. STBMalso have a direct effect on endothelial cells -downregulate proliferation and activation.Upregulation of cytok<strong>in</strong>es.MORE OF ALL THIS CAN RESULT INPRE-ECLAMPSIA!


Pre-eclampsiaeclampsia (PE)• Pregnancy-associatedassociated complication• Characterized by hypertention, prote<strong>in</strong>uria and activation ofmaternal endothelium• Risk of PE is 2.5% <strong>in</strong> unselected Norwegian pregnancies• Abnormal <strong>in</strong>teraction between maternal and fetal tissues dur<strong>in</strong>gplacentation• Trophoblast <strong>in</strong>vasion <strong>in</strong> the uter<strong>in</strong>e spiralarteries is limited →hypoxia and release of factors to maternal circulation →maternal vascular endothelial cell dysfunction• Increased level of ROS, pro<strong>in</strong>flammatory cytok<strong>in</strong>es, subsequentendothelial activation and <strong>in</strong>flammationMAY BE AN ABNORMAL PREGNANCY IN A NORMAL WOMANORMAY BE A NORMAL PREGNANCY IN AN ABNORMAL WOMAN


Suggested two-stagemodel for PEREDUCEDPLACENTALPERFUSION(stage 1)MATERNALCONSTITUTIONALFACTORS (genetic,environmental, obestity,diabetes, diet)OXIDATIVE STRESSACTIVATEDMATERNALENDOTHELIUMPRE-ECLAMPSIA(stage 2)Modified from Roberts J et al. Lancet 1999;354:788.


Trophoblast <strong>in</strong>vasion of the deciduaDeciduaMyometriumMoffet-K<strong>in</strong>g A, Nature Rev Immunol 2002; 2 (9): 656.


Fail<strong>in</strong>g the ”pregnancy test”Event thresholdNormal pregnancyPathology giv<strong>in</strong>g eventsMETABOLIC DEMANDS EXCEED BUFFERING CAPACITIES


Metabolic syndrome• Hallmarks: obesity,disturbance ofglucose metabolism,dyslipidemia andhypertension• Risk factors forcardiovasculardiseases• Runs <strong>in</strong> families –genetic basis?• Severe <strong>in</strong>creasedur<strong>in</strong>g the recentyears (age, women)http://archimede.bibl.ulaval.ca/archimede/files/4ae1756d-dc83-4b9d-8c80-a5df2dfe51f0/22151004.jpg


INFLAMMATORY RESPONSEENDOTHELIAL DYSFUNCTIONMETABOLICSYNDROMEINSULIN RESISTANCEPRE-ECLAMPSIADYSLIPIDAEMIAHDL, TGCOAGULATIONDISTURBANCES


Pregnancy represents a considerablemetabolic and vascular ”stress” testWomen with pregnancies complicated by IUGR, pre-eclampsia and/or premature deliveries have <strong>in</strong>creasedrisk for cardiovascular diseasesLOW BIRTHWIGHT 4.3PREMATURE DELIVERY 5.2PRE-ECLAMPSIA ECLAMPSIA 17.2


Pre-eclampsiaeclampsia vscardiovascular disease• Both are <strong>in</strong>flammatory disorders:Endothelial dysfunction andactivation, <strong>in</strong>creased levels ofoxidative stress markers andpro<strong>in</strong>flammatory cytok<strong>in</strong>es• PE is associated with an <strong>in</strong>creased riskof later life CVD• Inflammatory cytok<strong>in</strong>e/cytok<strong>in</strong>eRgene polymorphisms → <strong>in</strong>creased PErisk• Increased frequency of other genevariants <strong>in</strong>volved <strong>in</strong> <strong>in</strong>flammation <strong>in</strong>HUNT2 PE cases (SEPS1,(ACVR2)• CVD: polymorphisms of genes<strong>in</strong>volved <strong>in</strong> specific biochemicalpathways related todevelopment/progression ofatherosclerosis


Toll-likelike receptors (TLRs)http://www.mcb.uiuc.edu/faculty_research/images/tapp<strong>in</strong>g.jpg


Toll-likelike receptors (TLRs)• Activation of TLRs <strong>in</strong>itiates a series of signal<strong>in</strong>g events that trigger<strong>in</strong>nate immune responses through NF-κB-dependent and IRF-dependent signal<strong>in</strong>g pathways, <strong>in</strong>duc<strong>in</strong>g expression ofpro<strong>in</strong>flammatory genes (cytok<strong>in</strong>es, IFNs and chemok<strong>in</strong>es).• TLRs are PRRs that collectively recognize PAMPs (lipids,carbohydrate, peptide and nucleic-acidstructures) ) and DAMPs(celldamage and cellular stress-signals;signals; Hsp, , fibr<strong>in</strong>ogen, heparansulfat, HMGB1). DAMPs possess <strong>in</strong>flammatory properties, , andsignal ma<strong>in</strong>ly through TLR2, TLR4 and RAGE.• HMGB1 is released from necrotic cells, <strong>in</strong>duc<strong>in</strong>g <strong>in</strong>flammation andthe recruitment of mononuclear cells to the site of tissue damage.• The <strong>human</strong> placenta also releases HMGB1 and thus has thepotential to mount <strong>in</strong>flammation. Elevated decidual HMGB1expression has been suggested a role <strong>in</strong> development of PE.• HMGB1-mediated<strong>in</strong>flammatory response has also been implicated<strong>in</strong> the pathogenesis of CVD.


TLRs <strong>in</strong> pregnancyKoga, K. & Mor, G. Repr. Sci. 2008; 15 (3): 231-242.


TLR polymorphisms (SNPs)• Inflammatory diseases- asthma, allergy and atopic eczema <strong>in</strong> children- type 1 diabetes- Chron’s disease• Pregnancy complications- premature birth, low birth weight- maternal anemia- chorionic plate <strong>in</strong>flammation- <strong>in</strong>creased susceptibility to <strong>in</strong>fections <strong>in</strong> pregnancy• Cardiovascular diseases- acute coronary events- reduced carotid artery <strong>in</strong>tima-mediamedia thickness, decreased risk of atherogenesis- atherosclerosis


To summarize…• TLR2, TLR4 and TLR9 play a role <strong>in</strong> <strong>in</strong>flammation – and thus,probably <strong>in</strong> diseases caused by abnormal <strong>in</strong>flammatory reactions.• It seems likely that knowledge ga<strong>in</strong>ed about genes of <strong>in</strong>fluence <strong>in</strong>PE pathogenesis also will provide <strong>in</strong>sight <strong>in</strong>to genetic factorsrelevant to CVD – and vice versa.• S<strong>in</strong>ce CVD manifestations and gene regulation are <strong>in</strong>fluenced bygender, the ”PE-approach” may provide useful <strong>in</strong>formationabout gender specific phenomena <strong>in</strong> CVD.


HUNTThe Nord-TrTrøndelagHealth Study• HUNT 1, 2 & 3• 130 000 <strong>in</strong>habitants <strong>in</strong> Nord-Trøndelagcounty ~ 70% participated• Stable/homogenous population• Peripheral blood wasretrieved and stored<strong>in</strong> HUNT Biobank• Case/control study(geneticsand pre-eclampsia)• SNP genotyp<strong>in</strong>g(SNPlex, Illum<strong>in</strong>a)• GWAS (Illum<strong>in</strong>a(Illum<strong>in</strong>a)HUNT Biobank, Levanger


Thanks for your attention!☺Suggested read<strong>in</strong>g:1. Borzychowski AM et al. Inflammation and pre-eclampsiaeclampsia. Fetal andNeonatal Medic<strong>in</strong>e 2006; 11: 309.2. Koga K et al. Toll-likelike receptors and pregnancy: : Trophoblasts asmodulators of the immune response. J Obstet Gynaecol Res 2009;35 (2):191.3. Patni S et al. An <strong>in</strong>troduction to Toll-likelike receptors and their possiblerole <strong>in</strong> the <strong>in</strong>itiation of labour. BJOG 2007; 114: 1326.4. Sibai B et al. Pre-eclampsiaeclampsia. Lancet 2005; 365: 785.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!